Oral Medication

Okay, pills for MS are not yet available, but they are coming soon. Soon is a word we hear about medical trials quite often. We do not know exactly when soon means, but we are closer than ever before.

There are five, yes, five different possibilities of oral medications in trials at this time. The first two approved will probably be cladrbrine and fingolimad. Familiar names — coming soon to a pharmacist near you.

Many of us with MS have been waiting for these two oral medications to reach the market. When it happens, I hope there are plenty of pills and that they make a difference in our lives!

My Card for You

For the Christmas Tree, Garry used IFL Labs software for the fractal and Jasc animation software for the animation.

Pioneers in Research

The University of Texas Southwestern (UTSW) is one of 23 schools nationwide to receive a grant from Howard Hughes Medical Institute (HHMI), called Med to Grad, helping Ph.D students learn to move laboratory research to clinical trials.

Dr. Helen Yin started the program at UTSW, calling the participating students pioneers.

"This major grant from HHMI is a creative initiative that highlights the fundamental linkage among our core missions of education, research and patient care," said Dr. Daniel K. Podolsky, president of UT Southwestern. "It will significantly further out highest priorities as an academic medical center committed to biomedical research and its translation into innovative patient care."